Ya‐Hsuan Chang

1.2k total citations
42 papers, 624 citations indexed

About

Ya‐Hsuan Chang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ya‐Hsuan Chang has authored 42 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Ya‐Hsuan Chang's work include Lung Cancer Treatments and Mutations (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Gut microbiota and health (6 papers). Ya‐Hsuan Chang is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Acute Lymphoblastic Leukemia research (8 papers) and Gut microbiota and health (6 papers). Ya‐Hsuan Chang collaborates with scholars based in Taiwan, United States and Japan. Ya‐Hsuan Chang's co-authors include Hsuan‐Yu Chen, Pan‐Chyr Yang, Kuo‐Yen Huang, Hsin‐Jung Li, Chi‐Yuan Chen, Tong‐Hong Wang, Chung‐Ming Chen, Shuenn‐Chen Yang, Chia-Ching Lin and Han‐Chung Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Hepatology.

In The Last Decade

Ya‐Hsuan Chang

38 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya‐Hsuan Chang Taiwan 16 287 125 117 117 69 42 624
Alice Wang United States 16 377 1.3× 141 1.1× 116 1.0× 102 0.9× 45 0.7× 35 933
Mohamed I. Saad Australia 17 321 1.1× 148 1.2× 127 1.1× 119 1.0× 84 1.2× 34 791
Joel Mefford United States 15 282 1.0× 126 1.0× 231 2.0× 98 0.8× 41 0.6× 35 767
Dikaia Xenaki Australia 14 326 1.1× 153 1.2× 73 0.6× 132 1.1× 124 1.8× 33 678
Lihua Wu China 11 357 1.2× 39 0.3× 163 1.4× 65 0.6× 52 0.8× 39 828
Yuyang Li China 17 313 1.1× 91 0.7× 99 0.8× 197 1.7× 70 1.0× 49 758
Susan Kennedy United States 9 247 0.9× 151 1.2× 55 0.5× 73 0.6× 133 1.9× 10 659
Silvia Udali Italy 13 480 1.7× 70 0.6× 49 0.4× 141 1.2× 63 0.9× 30 796

Countries citing papers authored by Ya‐Hsuan Chang

Since Specialization
Citations

This map shows the geographic impact of Ya‐Hsuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Hsuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Hsuan Chang more than expected).

Fields of papers citing papers by Ya‐Hsuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Hsuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Hsuan Chang. The network helps show where Ya‐Hsuan Chang may publish in the future.

Co-authorship network of co-authors of Ya‐Hsuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Hsuan Chang. A scholar is included among the top collaborators of Ya‐Hsuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Hsuan Chang. Ya‐Hsuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Ya‐Hsuan, Xin Xing, Anna Chen, et al.. (2025). Ketogenic Diet Modulates Gut Microbiota–Brain Metabolite Axis in a Sex‐ and Genotype‐Specific Manner in  APOE4 Mice. Journal of Neurochemistry. 169(9). e70216–e70216.
2.
Wu, Chih‐Ying, et al.. (2025). E3 ligase TRIM8 suppresses lung cancer metastasis by targeting MYOF degradation through K48-linked polyubiquitination. Cell Death and Disease. 16(1). 88–88. 1 indexed citations
3.
Jou, Shiann‐Tarng, Meng‐Yao Lu, Kai‐Hsin Lin, et al.. (2024). Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia. Pathology - Research and Practice. 256. 155287–155287.
4.
Chang, Ya‐Hsuan, Yi‐Ju Chen, Min‐Shu Hsieh, et al.. (2024). Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma. Lung Cancer. 191. 107791–107791. 2 indexed citations
5.
Chen, Chi‐Yuan, Kuo‐Yen Huang, Chih‐Cheng Chen, et al.. (2024). The role of PM2.5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications. EMBO Molecular Medicine. 17(1). 31–40. 18 indexed citations
6.
Wang, Tong‐Hong, Kuo‐Yen Huang, Chih‐Cheng Chen, et al.. (2023). PM2 .5 promotes lung cancer progression through activation of the AhR‐TMPRSS2‐IL18 pathway. EMBO Molecular Medicine. 15(6). e17014–e17014. 49 indexed citations
7.
Wu, Ming‐Fang, et al.. (2023). Regulation of dendritic cell maturation in osimertinib-treated lung adenocarcinoma patients. Journal of the Formosan Medical Association. 122(9). 955–960. 2 indexed citations
8.
Chang, Ya‐Hsuan, Lucille M. Yanckello, George E. Chlipala, et al.. (2023). Prebiotic inulin enhances gut microbial metabolism and anti-inflammation in apolipoprotein E4 mice with sex-specific implications. Scientific Reports. 13(1). 15116–15116. 10 indexed citations
9.
Chang, Ya‐Hsuan, Shiann‐Tarng Jou, Chien‐Yu Lin, et al.. (2022). A microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols. PubMed Central. 1 indexed citations
10.
Yanckello, Lucille M., Ya‐Hsuan Chang, George E. Chlipala, et al.. (2022). Inulin supplementation prior to mild traumatic brain injury mitigates gut dysbiosis, and brain vascular and white matter deficits in mice. PubMed. 1. 8 indexed citations
11.
Huang, Hsin‐Yi, Yung‐Li Yang, Ya‐Hsuan Chang, et al.. (2022). Integration of immunohistochemistry, RNA sequencing, and multiplex ligation‐dependent probe amplification for molecular classification of pediatric medulloblastoma. Pediatric Blood & Cancer. 69(4). e29569–e29569. 1 indexed citations
12.
Yang, Ching‐Yao, Yen‐Ting Lin, Li‐Ju Lin, et al.. (2022). Stage Shift Improves Lung Cancer Survival: Real-World Evidence. Journal of Thoracic Oncology. 18(1). 47–56. 38 indexed citations
13.
Yanckello, Lucille M., Brian Fanelli, Scott McCulloch, et al.. (2022). Inulin Supplementation Mitigates Gut Dysbiosis and Brain Impairment Induced by Mild Traumatic Brain Injury during Chronic Phase. PubMed. 4(2). 50–64. 16 indexed citations
14.
Li, Hsin‐Jung, Feng-Yi Ke, Chia-Ching Lin, et al.. (2021). ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling–Driven Epithelial-to-Mesenchymal Transition. Cancer Research. 81(15). 4094–4109. 101 indexed citations
15.
Lin, Chia‐Yi, Kuo‐Yen Huang, Yi‐Chun Lin, et al.. (2021). Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer. Cancer Letters. 508. 76–91. 20 indexed citations
16.
Chang, Ya‐Hsuan, Shiann‐Tarng Jou, Kai‐Hsin Lin, et al.. (2021). Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia. Scientific Reports. 11(1). 769–769. 15 indexed citations
17.
Huang, Poyin, Yuan‐Han Yang, Ya‐Hsuan Chang, et al.. (2020). Association of early-onset Alzheimer’s disease with germline-generated high affinity self-antigen load. Translational Psychiatry. 10(1). 146–146. 8 indexed citations
18.
Lin, Chien‐Yu, Ya‐Hsuan Chang, Kai‐Hsin Lin, et al.. (2020). Childhood acute lymphoblastic leukemia mercaptopurine intolerance is associated with NUDT15 variants. Pediatric Research. 89(1). 217–222. 11 indexed citations
19.
Huang, Poyin, Cheng‐Sheng Chen, Yuan‐Han Yang, et al.. (2018). REST rs3796529 Genotype and Rate of Functional Deterioration in Alzheimer’s Disease. Aging and Disease. 10(1). 94–94. 3 indexed citations
20.
Chang, Ya‐Hsuan, Chung‐Ming Chen, Hsuan‐Yu Chen, & Pan‐Chyr Yang. (2015). Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma. Scientific Reports. 5(1). 10979–10979. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026